NAMS has an insider buy conviction of 1%, compared to the Unknown sector buy average of 6%.
Insider Trading Summary & Commentary
Automated executive transaction analysis for NAMS
Over the last 90 days, corporate insiders at NAMS (NAMS) engaged in a total of 100 transactions reported via SEC Form 4 filings. Among these, 8 were open-market purchases and 45 were sales. The total volume of insider trading reached $107.99M.
The net insider activity for NAMS shows a net selling bias of $106.73M. This activity represents a 1% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 6.81M shares valued at $27.29B on Mar 4, 2025.
Live Market News & Developments
Aggregated real-time headlines for NAMS (NAMS)
6 updates
NewAmsterdam Pharma (NAMS) Stock Looks Above Fair Value After Its 139% Run
Yahoo Finance62d ago
NewAmsterdam Pharma: Potential Coupled With Uncertainty (NASDAQ:NAMS)
Seeking Alpha73d ago
Revenue Downgrade: Here's What Analysts Forecast For NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS)
Simply Wall St2d ago
A Look At NewAmsterdam Pharma (NAMS) Valuation After Recent Share Price Weakness
Yahoo Finance162d ago
$NAMS stock is down 10% today. Here's what we see in our data. | NAMS Stock News
Quiver Quantitative72d ago
NewAmsterdam Pharma (NAMS) director sells shares to cover tax bill
Stock Titan72d ago
FAQs About NAMS Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for NAMS.
Based on SEC Form 4 disclosures, the Insider Confidence Score for NAMS is currently 50/100, which reflects a neutral / balanced bias. This calculation accounts for a total of 8 purchases and 45 sales by company executives over the last 90 days.
The CEO Conviction Index for NAMS is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.
No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.